Additional Details
-
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases
Miami VA Healthcare SystemMiami FL. 33125 -
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases
Columbia University Medical Center-New York Presbyterian HospitalNew York NY. 10024 -
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases
University of Kansas Medical CenterKansas City KS. 66160 -
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases
Massachusetts General HospitalBoston MA. 02114 -
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases
Brigham and Women's HospitalBoston MA. 02115 -
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases
Northwestern UniversityChicago IL. 60611 -
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases
NYU Langone HealthNew York NY. 10017 -
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases
University of Pittsburgh Medical CenterPittsburgh PA. 15213 -
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases
University of Alabama at BirminghamBirmingham AL. 35294 -
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases
Augusta UniversityAugusta GA. 30912 -
A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis
University of Utah HealthSalt Lake City UT. 84108 -
A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis
University of Kansas Medical CenterKansas City KS. 66160 -
A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis
Temple University HospitalPhiladelphia PA. 19140 -
A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis
Keck School of Medicine at USCLos Angeles CA. 90033 -
A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis
Pulmonix, LLCGreensboro NC. 27403 -
A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis
Southeastern Research CenterWinston-Salem NC. 27103 -
A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis
National Jewish HealthDenver CO. 80206 -
A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis
Y & L Advance Health Care, Inc. d/b/a Elite Clinical ResearchMiami FL. 33144 -
Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes
UCLA Health Westwood Medical PlazaWestwood CA. 90095 -
Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes
University of MinnesotaMinneapolis MN. 55455